Aptose Biosciences Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Product Pipeline
    • Overview
    • Luxeptinib for B-cell Tumors
    • Luxeptinib for Myeloid Tumors
    • HM43239 for AML
    • Posters & Presentations
  • Clinical Trials
    • Overview
    • Luxeptinib for CLL & NHL
    • Luxeptinib for AML
    • HM43239 for AML
    • Expanded Access
  • News
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • SEDAR
    • Governance
  • Careers
  • Contact

Press Releases

News

News

  • Press Releases
  • Presentations
  • Events

Aptose To Release Third Quarter Ended September 30, 2016 Financial Results and Hold Conference Call on November 15, 2016

Nov 10, 2016 7:00am EST

Aptose to Present New APTO-253 Data at the 2016 ASH Annual Meeting

Nov 03, 2016 4:15pm EDT

Aptose Provides Update on FDA Clinical Hold of APTO-253

Oct 13, 2016 7:00am EDT

Aptose Submits Formal Response to Clinical Hold for APTO-253

Sep 12, 2016 8:00am EDT

Aptose Biosciences Reports Financial Results for the Second Quarter Ended June 30, 2016

Aug 09, 2016 4:15pm EDT

Aptose Biosciences to Present at Canaccord Genuity 36th Annual Growth Conference

Aug 09, 2016 8:00am EDT

Aptose To Release Second Quarter Ended June 30, 2016 Financial Results and Hold Conference Call on August 9, 2016

Aug 04, 2016 4:15pm EDT

Aptose Biosciences Announces Results of Annual Meeting of Shareholders

Jun 21, 2016 4:10pm EDT

Aptose Biosciences Provides Corporate Update in Advance of Annual Meeting of Shareholders

Jun 21, 2016 8:00am EDT

Aptose Biosciences and CrystalGenomics Announce Exclusive Agreement for Non-Covalent BTK / FLT3 / AURK Inhibitor

Jun 08, 2016 8:00am EDT
RSS
  • Prev
    • 1...
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    • 22
    • 23
    • 24
    Next
    © 2022 Aptose Biosciences Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap